H.R. 2802 · 109th Congress
Drug Testing Integrity Act of 2005
- Stage
- In committee
- Sponsor
- Eliot Engel
- Introduced
- 2005-06-08
- Latest action
- 2005-06-17 · Referred to the Subcommittee on Commerce, Trade and Consumer Protection.
Summary
Drug Testing Integrity Act of 2005 - Declares it is unlawful to: (1) knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist the use of such product to defraud a drug test (that is, to submit a substance that purports to be from an individual other than its actual source, or purports to have been excreted or collected other than when it was actually excreted or collected); or (2) engage in any other conduct with the intent to produce a false or misleading outcome of a test for the presence of a controlled substance.
Grants the Federal Trade Commission enforcement powers as a violation of an unfair or deceptive act or practice.